Attached files
| file | filename |
|---|---|
| EX-31.1 - CERTIFICATION PURSUANT TO 18 U.S.C. SS 1350, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 - Gala Pharmaceutical Inc. | ex_31-1.htm |
| 10-Q - Gala Pharmaceutical Inc. | gala-global_10q.htm |
| EX-17 - Gala Pharmaceutical Inc. | ex_17-0.htm |
EXHIBIT 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, Allison Hess, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
| (1) | the Quarter Report on Form 10-Q of Gala Global Inc. for the quarter ended August 31, 2016 (the "Report") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| (2) | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Gala Global Inc. |
|
Dated: November 4, 2016
|
||
|
/s/ Allison Hess
|
||
|
Allison Hess
|
||
|
President, Chief Financial Officer, and Director
|
||
|
(Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer)
|
||